IRIS
BELCARO, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.729
AS - Asia 6.221
EU - Europa 5.720
SA - Sud America 1.201
AF - Africa 107
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 15
AN - Antartide 1
Totale 21.037
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.574
SG - Singapore 2.418
CN - Cina 1.634
BR - Brasile 960
UA - Ucraina 931
IE - Irlanda 903
IT - Italia 714
VN - Vietnam 695
TR - Turchia 689
RU - Federazione Russa 685
SE - Svezia 576
GB - Regno Unito 518
FR - Francia 421
DE - Germania 390
IN - India 248
FI - Finlandia 201
HK - Hong Kong 133
AR - Argentina 118
PL - Polonia 110
ID - Indonesia 67
MX - Messico 65
CA - Canada 56
ES - Italia 47
BD - Bangladesh 43
JP - Giappone 43
EC - Ecuador 42
BE - Belgio 39
KR - Corea 38
AU - Australia 36
NL - Olanda 36
ZA - Sudafrica 34
AT - Austria 29
IQ - Iraq 29
TH - Thailandia 29
PK - Pakistan 25
CZ - Repubblica Ceca 24
IR - Iran 23
PY - Paraguay 21
CO - Colombia 19
CH - Svizzera 16
TN - Tunisia 16
EG - Egitto 15
TW - Taiwan 15
PT - Portogallo 14
VE - Venezuela 14
EU - Europa 13
JO - Giordania 12
SA - Arabia Saudita 12
CL - Cile 11
GR - Grecia 10
LT - Lituania 10
MA - Marocco 10
PE - Perù 10
UZ - Uzbekistan 10
MY - Malesia 9
PH - Filippine 9
SK - Slovacchia (Repubblica Slovacca) 8
IL - Israele 7
JM - Giamaica 7
NI - Nicaragua 7
NZ - Nuova Zelanda 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
KE - Kenya 6
DK - Danimarca 5
HR - Croazia 5
KZ - Kazakistan 5
NP - Nepal 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
KW - Kuwait 4
SV - El Salvador 4
AL - Albania 3
BG - Bulgaria 3
BO - Bolivia 3
ET - Etiopia 3
LU - Lussemburgo 3
OM - Oman 3
UY - Uruguay 3
CG - Congo 2
GA - Gabon 2
GT - Guatemala 2
MK - Macedonia 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
SC - Seychelles 2
SI - Slovenia 2
SO - Somalia 2
TG - Togo 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
Totale 21.020
Salva come PNG Salva come JPEG
Città #
Singapore 1.710
Jacksonville 1.182
Chandler 906
Dublin 896
San Jose 688
Princeton 438
Ashburn 431
Dallas 373
Izmir 363
Nanjing 349
Southend 346
Beijing 331
Ho Chi Minh City 253
Wilmington 190
Santa Clara 189
Cambridge 188
Altamura 183
Hanoi 158
Los Angeles 158
Ann Arbor 129
Tongling 129
Nanchang 120
Hong Kong 114
Dearborn 110
The Dalles 99
Moscow 89
New York 79
São Paulo 75
Boardman 72
Buffalo 68
Redondo Beach 66
Kraków 65
Shenyang 63
Hebei 56
Kunming 48
Tianjin 48
Woodbridge 44
Jiaxing 41
Munich 41
Da Nang 40
Orem 38
Tokyo 34
Warsaw 34
Catania 32
Changsha 31
London 31
Milan 31
Rome 31
Norwalk 30
Brussels 29
Rio de Janeiro 29
Atlanta 26
Chennai 26
Haiphong 26
Washington 25
Seattle 24
Boston 23
Frankfurt am Main 23
Chieti 22
Hangzhou 22
Ankara 21
Falls Church 21
Brooklyn 20
Chicago 20
Curitiba 20
Denver 20
Houston 20
Sydney 20
Vienna 20
Guangzhou 19
Mexico City 19
Hefei 18
Manchester 18
Amsterdam 17
Istanbul 17
Johannesburg 17
Lanzhou 17
Mumbai 17
Belo Horizonte 16
Brno 16
Grevenbroich 16
Biên Hòa 15
San Mateo 15
Guayaquil 14
Helsinki 14
Hải Dương 14
Jinan 14
Montreal 14
Shanghai 14
Foggia 13
Pune 13
Thái Bình 13
Bangkok 12
Changchun 12
Ningbo 12
Quito 12
Seoul 12
Toronto 12
Augusta 11
Bengaluru 11
Totale 12.131
Salva come PNG Salva come JPEG
Nome #
Supplementary prevention and management of asthma with quercetin phytosome: a pilot registry 457
Beanblock® (standardized dry extract of Phaseolus vulgaris) in mildly overweight subjects: a pilot study. 195
Aescin and microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 163
A short-term vs a long-term infusion plan. A 20-week, European randomized trial. Analysis of efficacy and costs. 160
Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study 157
Venoruton vs Daflon: evaluation of effects on qualità of life chronic venous insuffciency 156
Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study). 155
Centella asiatica (Centellicum®) facilitates the regular healing of surgical scars in subjects at high risk of keloids. 155
Robuvit® and endurance in triathlon: improvements in training performance, recovery and oxidative stress 152
An open, supplement, registry study Arborvitae (R) for prevention of arthrosis-related pain during exercise 152
Incidence of perioperative stroke during peripheral revascularization or aortocoronary bypass in patients with carotid bruit and stenosis 151
The lung in systemic vasculitis: Radiological patterns and differential diagnosis 146
Topical heparin: New observations 145
Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension 142
Postoperative pulmonary infections: role of antibiotic treatment 142
Mononucleosis-related fatigue: supplementary management with Robuvit®. 141
Prevention of edema and flight microangiopathy with Venoruton (HR), (0-[beta-hydroxyethyl]-rutosides) in patients with varicose veins 139
Improvement in mood, oxidative stress, fatigue, and insomnia following supplementary management with Robuvit® 138
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings 137
[Breast cancer. Epidemiology and other factors related to incidence in various populations]. 136
Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study 136
Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study 134
Jet-lag: prevention with Pycnogenol. Preliminary report: evaluation in healthy individuals and in hypertensive patients 133
Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). 133
[European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication] 131
Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 131
Treatment of ankle sprain in patients with vascular diseases of the lower limbs 131
Treatment of Osteoarthritis with Pycnogenol®. The SVOS (San Valentino Osteo-arthrosis Study). Evaluation of Signs, Symptoms,Physical Performance and Vascular Aspects 130
TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper. 130
Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. 129
Effects of pycnogenol on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. 129
Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. 129
Diabetic ulcers: microcirculatory improvement and faster healing with pycnogenol. 128
Clinical evaluation of defibrotide in the treatment of arterial and venous vascular disease. A preliminary report. 128
Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment. 128
A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study 127
Management of superficial vein thrombosis and thrombophlebitis: status and expert opinion document. 126
[Comparison of netilmicin with other aminoglycosides in severe surgical infections]. 126
Circulating endothelail cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: improvement with venoruton 125
Behçet syndrome: effects of Pycnogenol® supplementation during regression phases. 125
Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella Asiatica: a clinical prospective randomized trial with a microcirculatory model. 124
Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria 124
Clinical improvement in chronic venous insufficiency signs and symptoms with Venoruton® (HR): an 8-month, open-registry, cost-efficacy study. 123
Superficial vein thrombosis (SVT), diffusion of thrombotic diseases, and increased global thrombogenicity: SVT as an important spy disease indicating environmental contamination by estrogens - Introduction 123
Prevention of recurrent venous thrombosis and post-thrombotic syndrome. 123
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial 123
Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol. 120
5-Year Control and Treatment of Edema and Increased Capillary Filtration in Venous Hypertension and Diabetic Microangiopathy Using O-(β-Hydroxyethyl)-Rutosides: A Prospective Comparative Clinical Registry 120
Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome 120
Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study 120
Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. 119
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 119
Interaction study between antiplatelet agents, anticoagulants, diabetic therapy and a novel delivery form of quercetin. 118
Venous ulcers: microcirculatory improvement and faster healing with local use of Pycnogenol 117
Thyroid cysts treatment with the sclerosing agent Atossiclerol. Long-term (5 to 15 years) follow-up. 117
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study 117
Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed® Versus Placebo 117
A controlled study shows daily intake of 50 mg of French Pine Bark Extract (Pycnogenol®) lowers plasma reactive oxygen metabolites in healthy smokers. 117
The value of segmental pressure measurement in the assessment of peripheral vascular disease. 116
Management of uncomplicated ankle sprains with topical or oral ketoprofen treatment. A registry study 116
Robuvit®: improvement of fatigue in medical convalescence. 116
Capillary filtration in venous hypertension: evaluation with the vacuum suction chamber device and strain-gauge plethysmography. 115
Improvement in signs and symptoms in psoriasis patients with Pycnogenol® supplementation. 115
Microcirculatory effects of Viatromb® spray gel heparin in chronic venous insufficiency: Evaluation of TcPO2 and PCO2 - A product evaluation study 115
Venous and diabetic ulcerations: management with topical multivalent silver oxide ointment. 113
Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth 113
Pycnogenolà supplementation improves health risk factors in subjects with metabolic syndrome 113
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European Study. 111
[Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin] 111
Improvement of common cold with Pycnogenol®: a Winter registry study. 111
O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study 109
Local heparin, superficial vein thrombosis 109
Cramps and Muscular Pain: Prevention with Pycnogenol((R)) in Normal Subjects, Venous Patients, Athletes, Claudicants and in Diabetic Microangiopathy 108
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 108
The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress 108
Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled Randomized Study. 107
Oxidative stress following administration of levothyroxine in subjects suffering from primary hypothyroidism. 107
Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study. 107
Pycnogenol may alleviate adverse effects in oncologic treatment 106
Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. 106
Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: a clinical, prospective, placebo-controlled, randomized, dose-ranging trial. 105
Computerized ultrasonic angiography. Current applications and comparison with other noninvasive and invasive methods 105
[Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs]. 105
Prevention of diffuse, minimal lymphatic "retention" with Robuvit®: a concept, supplement registry study 105
Oxygen-free radical decrease in hypertensive patients treated with lercanidipine 104
Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®). 104
Microcirculatory Effects of Total Triterpenic Fraction of Cenetlla asiatica in Chronic Venous Hypertension: Measurement by Laser Doppler, TcPo2-CO2, and Leg Volumetry 103
A controlled study of a lecithinized delivery system of curcumin (Meriva®) to alleviate the adverse effects of cancer treatment 103
Lady Prelox® improves sexual function in generally healthy women of reproductive age. 103
Mirtogenol® supplementation in association with dorzolamide-timolol or latanoprost improves the retinal microcirculation in asymptomatic patients with increased ocular pressure 103
The Efficacy of Sulodexide in the Prevention of Postthrombotic Syndrome 103
A plaster combining diclofenac and heparin: microcirculatory evaluation in 2 models of high-perfusion microangiopathy 101
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10 year follow-up study (the CAFES-CAVE Study). 100
Increase in Echogenicity of Echolucent Carotid Plaques After Treatment with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled, Randomized Trial. 100
Xerostomia: prevention with Pycnogenol® supplementation: a pilot study. 100
Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract 99
Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study 99
PycnoRacer®, a fitness drink including Pycnogenol®, improves recovery and training in the Cooper test 99
Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled study. 98
Rapid relief of signs/symptoms in chronic venous micronagiopathy with Pycnogenol: a prospective, controlled study. 98
Totale 12.546
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.510
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021146 0 0 0 0 0 0 0 0 0 92 19 35
2021/2022870 16 18 15 166 77 25 19 65 68 17 101 283
2022/20232.720 272 406 156 284 234 570 180 176 276 26 88 52
2023/20241.146 88 50 65 26 48 287 334 38 24 50 33 103
2024/20253.392 264 688 530 55 78 93 64 149 394 147 281 649
2025/20266.558 486 302 956 1.378 544 367 886 504 724 411 0 0
Totale 21.520